C Vallejo
Overview
Explore the profile of C Vallejo including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
69
Citations
594
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
De la Pinta C, Fernandez-Lizarbe E, Sevillano D, Capuz A, Hernanz R, Vallejo C, et al.
J Clin Transl Res
. 2020 Sep;
6(1):6-13.
PMID: 32875136
Background: Radiosurgery is employed for the treatment of brain metastases. The aim of this study is to evaluate the efficacy and tolerability of single-dose radiosurgery (SRS) compared to hypofractionated stereotactic...
2.
Bueno J, Alegre A, Lopez-Villar O, Querol S, Arroyo J, Goterris R, et al.
Bone Marrow Transplant
. 2019 Nov;
55(4):811-817.
PMID: 31690809
Although many experts position statements on autologous stem cell mobilization have been published, there are some aspects that are still under discussion. A Spanish Hematologist expert group was summoned to...
3.
Gonzalez-San Segundo C, Jove J, Zapatero A, Pastor-Peidro J, Vazquez M, Casana M, et al.
Clin Transl Oncol
. 2019 Jan;
21(8):1044-1051.
PMID: 30617939
Introduction: The clinical course in patients with prostate cancer (PCa) after biochemical failure (BF) has received limited attention. This study analyzes survival time from recurrence, patterns of progression, and the...
4.
Vallejo C, Fortun J
Rev Esp Quimioter
. 2018 Dec;
32(1):31-39.
PMID: 30547501
Objective: In recent years, the introduction of new antifungals for the prevention of invasive fungal infections (IFIs) in hemato- oncological patients, particularly extended-spectrum azoles, has led to a change in...
5.
De la Serna J, Sanz J, Bermudez A, Cabrero M, Serrano D, Vallejo C, et al.
Bone Marrow Transplant
. 2016 Mar;
51(7):961-6.
PMID: 26950372
The safety and efficacy of a 4-day myeloablative conditioning (MAC) regimen consisting of Bu 3.2 mg/kg and fludarabine 40 mg/m(2)/day for HLA-identical sibling allogeneic hematopoietic cell transplantation (HCT) in myeloid...
6.
Santos N, Rodriguez-Romanos R, Nieto J, Buno I, Vallejo C, Jimenez-Velasco A, et al.
Bone Marrow Transplant
. 2015 Sep;
51(1):79-82.
PMID: 26367234
Minor histocompatibility Ags (mHags) have been implicated in the pathogenesis of GVHD after allogeneic hematopoietic stem cell transplantation (HSCT). Uridine diphospho-glucuronosyltransferase 2B17 (UGT2B17) gene deletion may act as a mHag...
7.
Gomez A, Gonzalez J, Counago F, Vallejo C, Casas F, Rodriguez de Dios N
Clin Transl Oncol
. 2015 Aug;
18(4):331-41.
PMID: 26280402
Locally advanced non-small cell lung cancer (NSCLC) is a diversified illness in which postoperative radiation therapy (PORT) for complete resection with positive hiliar (pN1) and/or mediastinal (pN2) lymph nodes is...
8.
Fox M, Barba P, Heras I, Lopez-Parra M, Gonzalez-Vicent M, de la Camara R, et al.
Clin Microbiol Infect
. 2015 Feb;
21(1):e1-3.
PMID: 25636943
No abstract available.
9.
Bosch-Vizcaya A, Rodriguez-Romanos R, Nieto J, de la Camara R, Brunet S, Vallejo C, et al.
Bone Marrow Transplant
. 2014 Oct;
50(2):298-300.
PMID: 25330223
No abstract available.
10.
Blumel J, Chedraui P, Baron G, Benitez Z, Flores D, Espinoza M, et al.
Climacteric
. 2014 Jan;
17(4):433-41.
PMID: 24443950
Background: Menopausal hormone therapy (HT) has shown benefits for women; however, associated drawbacks (i.e. risks, costs, fears) have currently determined its low use. Objective: To determine the prevalence of current...